Clinical Trial Detail

NCT ID NCT03148795
Title A Study of Talazoparib in Men With DNA Repair Defects and Metastatic Castration-Resistant Prostate Cancer
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements no
Sponsors Pfizer
Indications

prostate adenocarcinoma

Therapies

Talazoparib

Age Groups: adult senior

No variant requirements are available.